Etizolam AKA 1-Methyl-6-o-chlorophenyl-8-ethyl-4H-s-triazolo[3,4-c]thieno[2,3-e]1,4-diazepine is a benzodiazepine analog. The molecular formula for Etizolam is C17H15ClN4S with an average mass of 342.845795 Da and a monoistopic mass of 342.070587 Da.
Etizolam (marketed underneath the brand Etilaam, Etizola, Sedekopan, Etizest, Pasaden or Depas) is antianxiety drug analog. The etizolam molecule differs from a antianxiety drug in that the benzene nucleus has been replaced by a thiophene ring and triazole ring has been united, creating the drug a thienotriazolodiazepine. It possesses amnesic, anxiolytic, antiepileptic drug, hypnotic, sedative and muscle relaxant properties.
Etizolam, a thienodiazepine derivative, is rapidly absorbed, with peak levels achieved between .5hr to 2 hrs. It’s a mean elimination half-life around 3.5 hours. Etizolam possesses potent hypnotic properties, and is a comparable alternative to short-acting benzodiazepines. Etizolam acts as a full agonist at the gaba receptor which in turn supplies its various therapeutic and adverse effects.
According to the Italian P.I. sheet, etizolam belongs to a brand new category of diazepines, thienotriazolodiazepines. This new category is well broken down, quickly metabolized, and incorporates a lower risk of accumulation, even once prolonged treatment. Etizolam has anxiety reducing properties about six times larger than that of benzodiazepine. Etizolam produces, particularly at higher dosages, rapid decrease in sleep onset, a rise in total sleep time, and rapid decrease within the range of awakenings. throughout tests, there have been no substantial changes in deep sleep; however, has shown to decrease total sleep time. In encephalogram tests of healthy volunteers, etizolam showed some similar characteristics to tricyclic antidepressant antidepressants.
This information has been derived from where etizolam is used as a medical treatment, however, etizolam bought from Savant-Research is sold solely for research purposes and not for human consumption.